NCT06553898View on ClinicalTrials.gov

Study of Therapeutic Efficacy of CAR-T Cell Therapy in Patients With MDR-SRNS

PHASE1RecruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

August 13, 2024

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2027

Conditions
Multi-Drug Resistant Nephrotic SyndromeCAR-T Cell Therapy
Interventions
BIOLOGICAL

anti-BCMA/CD70 CAR-T cells

Three dose groups (0.3×105/kg, 1×105/kg, 3×105/kg) were set up, starting from the low dose group climbing to explore the safe and effective dose.

Trial Locations (1)

Unknown

RECRUITING

Children's Hospital, Zhejiang University School of Medicine, Hangzhou

All Listed Sponsors
lead

The Children's Hospital of Zhejiang University School of Medicine

OTHER